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Abstract
Background: Modulation of the immune system is one of the principal roles of Vitamin D, for
which the effects are exerted via the vitamin D receptor (VDR). Importantly, variants in the VDR
gene have been susceptible in the past to raise the risk of asthma in several populations. These
effects of VDR allelic markers remain speculative in the Chinese Han population.
Results: A case-control study of 1090 individuals including 567 asthmatic patients was realized on
five SNPs within the VDR gene. Only rs7975232 (ApaI) marker showed a significant association
with asthma (P = 0.009). Haplotype analysis of the five VDR polymorphisms showed a significant
association with asthma (global-p value = 0.012).
Conclusion: Although the susceptibility of VDR gene variants with asthma could not be confirmed
for all SNPs tested in this study, the significant association obtained for rs7975232 provides
evidence for a previously unknown report about the Chinese Han population and may raise the
susceptibility of VDR to be a candidate gene for asthma.
Background
Recent discoveries made in the field of molecular biology
have reported that vitamin D derived from diet and sup-
plements is not a vitamin, but a steroid with immunosup-
pressive properties when elevated [1]. It has also been
linked with lessening symptoms of autoimmune diseases
like multiple sclerosis [2], Crohn's disease [3], and rheu-
matoid arthritis [4].
However, the effects of this steroid-like molecule are
essentially exerted via its cognate the vitamin D receptor
(VDR). In addition, molecular modeling findings have
defined an interaction between the hormonal 1, 25-dihy-
droxyvitamin D3 form and its receptor through a ligand-
binding domain (LBD) [5]. The activated VDR plays then
a fundamental role in the body by regulating numerous
primary target genes. Three years before, a Canadian study
has identified on a large scale that VDR may transcribe
more than 900 genes [6]. In fact, the interaction of 1,
25(OH)2D3 with VDR and its cofactors modulates many
biological activities of the neural, immune, and endocrine
systems; including calcium and phosphorous homeosta-
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sis, apoptosis and cell differentiation. For instance, a pre-
vious study has demonstrated that VDR rs7975232
polymorphism is associated with hip bone mineral den-
sity (BMD) in a group of 260 healthy postmenopausal
Chinese Han women [7].
Besides to this classical action, and due to the pleiotropic
effect the 1, 25(OH)2D3-VDR complex exerts, its genetic
variants have been found to be associated with a variety of
diseases/phenotypes, in which the risk can often depend
on inter-individual variability or genetic differences
within VDR protein; such like the heterogeneous pheno-
type of asthma. In fact, since VDR is located within the
region q13-26 of chromosome 12 previously linked to
asthma or related phenotypes in different populations [8-
12], it is considered to be one of the candidate genes of
asthma. A number of association studies were previously
conducted in different populations and ethnic groups.
Two of them have suggested associations among VDR pol-
ymorphisms and asthma. The first one was a family-based
study on a founder French population from northeastern
Quebec, accompanied by a second Canadian study, using
both the childhood asthma management network as fam-
ily-based study and the Healthy women from European
ancestry as a case-control study [13,14]. Another research
among a German population has also tested the same
hypothesis, however, there was no preferential transmis-
sion of VDR variants to children with asthma [15]. Assays
were also done on animal models, where an experimental
allergic asthma was induced in VDR knockout and wild-
type (WT) mice. As expected, WT mice developed symp-
toms of airway inflammation with an influx of eosi-
nophils, elevated Th2 cytokine levels, mucous
production, and airway hyperresponsiveness [16].
Thus, we sought to replicate the association previously
described between the VDR gene and asthma among a
Chinese Han population. Five Single nucleotide polymor-
phisms (SNPs) were selected, genotyped and statistically
analyzed in a case-control study including 1090 Chinese
individuals. Our results demonstrated that VDR
rs7975232 (ApaI) variant was associated with asthma sus-
ceptibility in the cohort studied.
Methods
Subjects
All subjects were Chinese of Han ethnic origin living in
the same urban area. This group form 99% of the local
population of Shandong, an eastern coastal province of
China. Of note, the ethnicity of the group was also evident
from the similar lifestyle and dietary habits. This research
is one of the association studies carried out in our Insti-
tute, where several asthma susceptibility genes with differ-
ent locations and functions were being tested to identify
some novel linkages to the complex phenotype of asthma
in the Chinese Han population. For that purpose, the
process of collecting the samples was done thanks to col-
laboration with a number of provincial Hospitals. Our
primary number of samples has increased since three
years [17-19] to a larger number, of which 567 cases and
523 controls were collected for this study. Detailed infor-
mation about age, sex, clinical characteristics and original
medical institution were obtained for all participants (see
Table 1). Healthy subjects, matched for age, were sampled
from both Shandong Provincial hospital and Qilu hospi-
tal in Jinan city, where they had undergone pulmonary
function tests, by which no doctor-diagnosed asthma nor
history of asthma or other pulmonary diseases were
noted. Whereas, affected subjects were recruited from
both Qilu Hospital and Weifang Asthma Hospital. The
314 females and 253 males all confirmed asthma diagno-
sis by spirometry, which was performed according to
American Thoracic Society recommendations (ATS,
1987); while no other atopy-related diseases or allergy
phenotypes were available for those patients. Blood sam-
ples were obtained from all participants with informed
consent. Genomic DNA was extracted from peripheral
blood leukocytes by a standard salting-out method. The
study was approved by the ethics review committee for
human studies at School of Medicine, Shandong Univer-
sity.
SNPs Selection and Genotyping
In this Case-control study, we tested five polymorphisms
of VDR gene, which maps to chromosome 12q13.11, con-
sists of 9 exons with at least 6 isoforms of exon 1, spans
63.5 kb, and encodes a 427-amino acid protein [20]. All
Table 1: Baseline characteristics of the asthmatic patients with asthma and controls.
Characteristics Patients(n = 567) Controls (n = 523)
Samples origins and Weifang (n = 424) 195/229 SPH (n = 308) 217/91
Sex distribution(male/female) Qilu Hospital(n = 143) 58/85 Qilu Hospital (n = 215) 143/72
Age: mean (range) 41.36 (4–77) 44.18 (18–79)
FEV1, % predicted 56.48 ± 16.8 85.98 ± 12.2
Changes in FEV1 by bronchodilator, % 28.28 ± 14.6 4.38 ± 3.9
Total frequency of females 55.4% 33.3%
Total frequency of males 44.6% 66.6%
SPH stands for Shandong Provincial HospitalBMC Medical Genetics 2009, 10:71 http://www.biomedcentral.com/1471-2350/10/71
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variants are candidate SNPs, which are known to have a
specified extent for asthma and/or other pulmonary dis-
eases described in the earlier researches among different
populations: rs2228570 or FokI [21], rs3782905 [13,14],
rs1544410 or BsmI [14], rs7975232 or ApaI [14,22], and
rs731236 or TaqI [14,15,23]. Two synonymous sites were
primary selected, rs2228570 (a T/C transition polymor-
phism in exon2) and rs731236 (a single base change C to
T in codon 352 at the 3' end of the VDR gene). Further, the
three other sites were investigated in the non-coding
regions of VDR gene, including rs7975232 and rs1544410
both in intron 8, and rs3782905 in intron 2. All markers
were analyzed by a standard PCR-restriction fragment
length polymorphism (PCR-RFLP) method. The different
loci were recognized by the following restriction endonu-
cleases (New England Biolabs NEB-China, Beijing): FokI
for C/T at 37°C in exon 2, TaqI for T/C at 65°C in exon 9,
BsmI for G/A at 65°C and ApaI for C/A at 37°C in intron
8, respectively and DdeI for C/G at 37°C in intron 2
(primers, product lengths and cycling conditions are all
summarized in Table 2).
Statistical Analysis
Single nucleotide polymorphisms were assessed for both
genotypic and allelic association analysis among asthma
patients and healthy controls. The genotype data of all
tested SNPs were then used to estimate Hardy-Weinberg
equilibrium by comparison of genotype frequencies
within the two groups by a χ2-test. P-values were calcu-
lated with SPSS statistical software (SPSS Statistics 17.0;
2008 SPSS Inc, Chicago, IL), where Fisher's exact test was
applied to analyze the comparison of the frequencies of
discrete variables between cases and controls. The odds
ratios (ORs) with 95% confidence intervals (95%CI) were
also calculated during the single site analysis to estimate
risk of asthma associated with the VDR polymorphic gen-
otypes. An adjustment for multiple tests by Bonferroni
correction in which the P-values are multiplied by the
Table 3: Genotypic and allelic association analysis of vitamin D receptor single-nucleotide polymorphisms in the Chinese asthma 
study.









rs2228570 CC 152 (0.29) 193 (0.34)
C 569 (0.54) 644 (0.57) 1.00 CT 265 (0.51) 258 (0.46)
T 477 (0.46) 490 (0.43) 1.10 (0.93–1.30) 0.261 TT 106 (0.20) 116 (0.20) 0.161
rs3782905 CC 378 (0.72) 415 (0.73)
C 895 (0.85) 972 (0.86) 1.00 CG 139 (0.27) 142 (0.25)
G 132 (0.15) 162 (0.14) 0.88 (0.69–1.13) 0.920 GG 6 (0.01) 10 (0.02) 0.754
rs1544410 GG 472 (0.90) 515 (0.91)
G 995 (0.95) 1079 (0.95) 1.00 GA 51 (0.01) 49 (0.08)
A 51 (0.05) 55 (0.05) 1.00 (0.68–1.48) 0.977 AA 0 (0.00) 3 (0.01) 0.208
rs7975232 CC 247 (0.47) 310 (0.55)
C 710 (0.68) 837 (0.74) 1.00 CA 216 (0.41) 217 (0.38)
A 336 (0.32) 297 (0.26) 1.33 (1.10–1.60) 0.002 AA 60 (0.12) 40 (0.07) 0.009
rs731236 TT 471 (0.90) 510 (0.90)
T 993(0.95) 1073 (0.95) 1.00 TC 51 (0.09) 53 (0.09)
C 53(0.05) 61(0.05) 0.94 (0.64–1.37) 0.446 CC 1 (0.01) 4 (0.01) 0.743
The P values < 0.05 are indicated in bold.
Allelic and genotypic frequencies of both controls and asthmatics are shown in parentheses.
Table 2: Different loci selected within the vitamin D receptor sequence and their corresponding primers used during PCR-RFLP 
method.
Location Locus Alleles PCR primer PCR Product (bp) Restriction enzyme RFLP products(bp)
Exon 2 rs2228570 C/T F: 5'-CCTGGCACTGACTCTGGCTCTG-3'
R: 5'-GGCTCCCTTCATGGA AACACCT-3'
270 FokI 207/63
Intron 2 rs3782905 C/G F: 5'-AAGACATGGTGTCTGCTTCA-3'
R: 5'-GGTTAGATCGATATGTTTGA-3'
304 DdeI 223/81
Intron 8 rs1544410 G/A F: 5'-GGTGGGACTGAAGAAGCTGAAC-3'
R: 5'-CTTTGGACCTCATCACCGACAT-3'
613 BsmI 357/256
Intron 8 rs7975232 A/C F: 5'-GTAGAATAGAAGGAGGGAAGC-3'
R:5'-AGAGGCAGCGGTACTGCTTGGAGTG-3'
662 ApaI 424/238
Exon 9 rs731236 T/C F: 5'-GTAGAATAGAAGGAGGGAAGC-3'
R: 5'-AGCTTCATGCTGCACTCAGGCT-3'
690 TaqαI 504/186BMC Medical Genetics 2009, 10:71 http://www.biomedcentral.com/1471-2350/10/71
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number of comparisons was later used to control the false
discovery rate. Haplotypes and their frequencies were also
constructed using the online software SHEsis http://anal
ysis.bio-x.cn/myAnalysis.php[24], in which differences of
haplotype distribution between patients and controls is
assessed by the Monte Carlo method. The differences in
pairwise distribution between respective pairs of SNPs
tested were assessed by the statistical measure of LD based
on calculating D' using Haploview 4.1[25]. Further, a
graphical representation of different genotype data
obtained with SNP rs7975232 was produced, using a
powerful program for analyzing graphs (Graphical Analy-
sis 3.4), in which the genotype frequencies of cases and
controls obtained with this site were diagrammatically
compared.
Results
For the five polymorphisms tested in this study within the
VDR gene sequence, genotype distributions were in
Hardy-Weinberg equilibrium in both patients and con-
trols (all P-value > 0.05). The first association result with
the coding polymorphisms VDR/rs2228570 and VDR/
rs731236, however negative, was important since it
excluded the susceptible risk. In fact, the statistical analy-
sis of these two SNPs did not call for any association with
asthma (P > 0.05). In the second part, three other SNPs
were tested within non-coding regions of VDR sequence,
VDR/rs3782905, VDR/rs7975232 and VDR/rs1544410.
In contrast to the marker rs7975232, the role of the
intronic variants rs3782905 and rs1544410 in asthma
could not be confirmed. Hence, among the five markers
studied, only intronic SNP rs7975232 (ApaI) was stand-
ing out as a significant polymorphism with an increased
risk in one group compared to the other (The genotype
analysis and the results of association tests for the five
markers are all represented in Table 3).
Importantly, rs7975232 has shown a strong association
with asthma in our Chinese samples, and the risk con-
ferred by it was slightly excessive (P = 0.009; Odds Ratio =
1.33; 95% CI: 1.10–1.60). In addition, after graphical rep-
resentation of its different genotypic frequencies distribu-
tion, the minor allele has demonstrated protective effect
in a recessive model in affected subjects, of which the cor-
Table 4: Detailed statistical analysis of VDR ApaI site in the Chinese cohort.
Allelic analysis Genotypic analysis
C A CC CA AA χ2 Global PP *
Odd 1.00 1.333 1.00 1.249 1.882
(95%CI) --- (1.10–1.60) (0.97–1.61) (1.22–2.90)
P value 0.002 --- 0.083 0.004 9.367 0.009 0.045
P values < 0.05 are indicated in bold.
P* corresponds to global P value adjusted by Bonferroni correction for multiple tests.
Frequency distribution of VDR-rs7975232 within the two groups (case/control) in the Chinese population studied Figure 1
Frequency distribution of VDR-rs7975232 within the two groups (case/control) in the Chinese population stud-
ied. The bars represent the frequencies of the 3 genotypes, CC, CA, AA, which are labeled by 1, 2, 3, respectively, in each 
group. We can clearly see that AA genotype is underrepresented in the group of asthmatic patients.BMC Medical Genetics 2009, 10:71 http://www.biomedcentral.com/1471-2350/10/71
Page 5 of 7
(page number not for citation purposes)
responding homozygote genotype AA was underrepre-
sented in the case data comparing to the control data
(Figure. 1).
Genotypic and allelic P-values were also calculated for
rs7975232 site through a detailed statistical analysis (see
Table 4). Also, when the difference for the same variant
was adjusted for multiple testing by the Bonferroni
method, the global significant association obtained was
still persisting (P = 0.045). One other significance level
was obtained with AA homozygote individuals (P =
0.004) in this analysis, and a highest odds ratio was also
estimated for the same genotype (Odds Ratio = 1.88, 95%
CI: 1.22–2.90). Consequently, these results suggest in all
likelihood that minor allele of rs7975232 marker is a risk
allele for asthma in our Chinese cohort studied.
Finally, evaluation of LD between each pair of loci has
determined one block on the LD plot structure ("Block 1";
see figure 2A/B), which spans a region of 26 kb between
two SNPs (rs3782905 and rs1544410); from intron 2
(position 46552434) to intron 8 (position 46526102).
However, LD in this region was considered low, which is
perhaps due to the low frequency seen with the minor
alleles of these two SNPs, since they may not affect the
"Block 1". Whereas, further in the 3'-terminal region more
significant D' measures were seen between the two pairs
rs1544410-rs7975232 and rs7975232-rs731236 (see fig-
ure 2A). This can probably explain the association
observed with the variant rs7975232 in this region. In
addition to this result, to investigate whether rs7975232
or neighboring non-polymorphic loci were causative,
haplotype association analysis was later conducted with
the complete five-locus haplotype studied (see Table 5).
The analysis has shown a significant global association
result with asthma (χ2 = 14.51, P = 0.012), where the
selected haplotype TCGAT has demonstrated the highest
significance association (P = 0.0005).
Discussion
This research directs an issue to test the hypothesis
described in the previous association studies between
VDR variants and asthma. Though the susceptibility for
asthma disease could not totally be confirmed for all SNPs
tested in this study, the significant result obtained with
the non-coding polymorphism rs7975232 has reported
previously unknown information about the relation exist-
ing between VDR gene and asthma in the Chinese Han
Table 5: Five-locus haplotype analysis for transmission 
disequilibrium test.
Haplotype Case(freq) Control(freq) χ2 P value
CCGCT 0.316 0.292 1.33 ...
CCGAT 0.097 0.108 0.79 ...
CGGCT 0.084 0.079 0.13 ...
TCGCT 0.282 0.247 3.42 ...
TCGAT 0.095 0.142 11.84 0.0005
TGGCT 0.030 0.032 0.09 ...
Global 14.51 0.012
Selected haplotype results are shown. Only significant (P ≤ .05) or 
global P values are listed.
All low frequency haplotypes (<3%) were discarded from the analysis 
by the software SHEsis.
The order of SNP: rs2228570-rs3782905-rs1544410-rs7975232-
rs731236
A. Pairwise linkage disequilibrium map (LD) of VDR markers  typed in this case-control study Figure 2
A. Pairwise linkage disequilibrium map (LD) of VDR 
markers typed in this case-control study. The position 
of each SNP along the chromosome 12 (region q13-11) is 
indicated on top. The statistical measure of LD or D' × 10-2 is 
known as the strength of LD between approximately evenly 
spaced SNPs. Common measure of LD represented here by 
different numbers on each square and progression of red 
color. One block was detected among VDR loci studied 
(Block 1).B. Different haplotypes found within the "Block 1" 
constituted of two SNPs (rs3782905 and rs1544410) and 
their corresponding frequencies.BMC Medical Genetics 2009, 10:71 http://www.biomedcentral.com/1471-2350/10/71
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population. This may also increase the probability of VDR
to be a candidate gene for asthma.
Our results represent also a replication of the previous
findings in the two U.S. studies, where SNP rs7975232
polymorphism has also shown a significant association
with asthma. In the CAMP, seven VDR polymorphisms
were genotyped in complete nuclear families from three
different ethnic groups included in the analysis. After a
stratified genetic analysis by ethnic groups, only intronic
variant rs7975232 has shown a significant association
with asthma (P = 0.01) [14]. However, the NHS on 517
cases and 519 controls has shown evidence for association
with asthma of four out of six VDR SNPs (rs7975232,
rs731236, rs2239185, and rs3782905) [14]. These results
have demonstrated a replication of rs7975232 VDR-locus
association with asthma among the Canadian women
samples. However, the two polymorphisms rs731236 and
rs3782905, which have reported a significant association
in the NHS, have not shown any association with asthma
in both Chinese population and Canadian families from
the CAMP study. Elsewhere, Poon and colleagues
addressed a study which involved a total of 223 independ-
ent French Northeastern Quebec families [13]. In contrast
to our result, their results have not demonstrated any
association between VDR rs7975232 association and
asthma; however, six other VDR variants widely studied
were significantly overtransmitted to both asthmatic and
atopic offspring (p < 0.05) in the French families. Another
study addresses the previously described association of
VDR variants with asthma and related phenotypic traits,
in which 951 German individuals from 224 pedigrees
were included in the analysis [15]. Thirteen SNPs were
tested and all reported no associations with asthma,
including three non-significant SNPs also typed in our
study (rs3782905, rs1544410 and the coding polymor-
phism rs731236).
Recently, researchers are following a key challenge to
understand the functionality of different VDR polymor-
phisms, by the fact that most of these markers are synon-
ymous. Most investigators have focused on the 3'
regulatory region, because it is close to the synonymous
markers tested mostly in association studies, such as BsmI,
ApaI, and TaqI. The importance of N-terminal regions of
the nuclear hormone receptors is increasingly recognized,
especially through regulation of mRNA stability [25].
Only several papers have tried to identify the relation
existing between significant associations and functional
sequence variations in the VDR gene. Although no con-
sistent association studies support those functionality
findings in asthma disease.
Conclusion
In summary, we identified a significant association
between a genetic variant at the VDR locus and asthma in
Chinese Han population. However, further studies are
needed to find out the genuine functional variants in this
region.
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